» Articles » PMID: 29229810

Disease Onset in X-linked Dystonia-parkinsonism Correlates with Expansion of a Hexameric Repeat Within an SVA Retrotransposon in

Abstract

X-linked dystonia-parkinsonism (XDP) is a neurodegenerative disease associated with an antisense insertion of a SINE-VNTR-Alu (SVA)-type retrotransposon within an intron of This unique insertion coincides with six additional noncoding sequence changes in , the gene that encodes TATA-binding protein-associated factor-1, which appear to be inherited together as an identical haplotype in all reported cases. Here we examined the sequence of this SVA in XDP patients ( = 140) and detected polymorphic variation in the length of a hexanucleotide repeat domain, (CCCTCT) The number of repeats in these cases ranged from 35 to 52 and showed a highly significant inverse correlation with age at disease onset. Because other SVAs exhibit intrinsic promoter activity that depends in part on the hexameric domain, we assayed the transcriptional regulatory effects of varying hexameric lengths found in the unique XDP SVA retrotransposon using luciferase reporter constructs. When inserted sense or antisense to the luciferase reading frame, the XDP variants repressed or enhanced transcription, respectively, to an extent that appeared to vary with length of the hexamer. Further in silico analysis of this SVA sequence revealed multiple motifs predicted to form G-quadruplexes, with the greatest potential detected for the hexameric repeat domain. These data directly link sequence variation within the XDP-specific SVA sequence to phenotypic variability in clinical disease manifestation and provide insight into potential mechanisms by which this intronic retroelement may induce transcriptional interference in expression.

Citing Articles

Principal variables analysis for non-Gaussian data.

Clark-Boucher D, Miller J J Comput Graph Stat. 2025; 34(1):374-383.

PMID: 40041743 PMC: 11875516. DOI: 10.1080/10618600.2024.2367098.


intronic expansion identified by poly-glycine-arginine pathology increases Alzheimer's disease risk.

Nguyen L, Ajredini R, Guo S, Romano L, Tomas R, Bell L Proc Natl Acad Sci U S A. 2025; 122(7):e2416885122.

PMID: 39937857 PMC: 11848317. DOI: 10.1073/pnas.2416885122.


RNA gain-of-function mechanisms in short tandem repeat diseases.

Davenport M, Swanson M RNA. 2024; 31(3):349-358.

PMID: 39725460 PMC: 11874975. DOI: 10.1261/rna.080277.124.


Triplex H-DNA structure: the long and winding road from the discovery to its role in human disease.

Hisey J, Masnovo C, Mirkin S NAR Mol Med. 2024; 1(4):ugae024.

PMID: 39723156 PMC: 11667243. DOI: 10.1093/narmme/ugae024.


Targeting Myeloperoxidase to Reduce Neuroinflammation in X-Linked Dystonia Parkinsonism.

Petrozziello T, Jalali Motlagh N, Monsanto R, Lei D, Murcar M, Penney E CNS Neurosci Ther. 2024; 30(11):e70109.

PMID: 39500625 PMC: 11537767. DOI: 10.1111/cns.70109.


References
1.
Sullivan A, Crawford D, Scott E, Leslie M, Sherman S . Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range. Am J Hum Genet. 2002; 70(6):1532-44. PMC: 379140. DOI: 10.1086/340846. View

2.
Yum K, Wang E, Kalsotra A . Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes. Curr Opin Genet Dev. 2017; 44:30-37. PMC: 5447468. DOI: 10.1016/j.gde.2017.01.007. View

3.
Malkowska M, Kokoszynska K, Rychlewski L, Wyrwicz L . Structural bioinformatics of the general transcription factor TFIID. Biochimie. 2012; 95(4):680-91. DOI: 10.1016/j.biochi.2012.10.024. View

4.
Belotserkovskii B, Mirkin S, Hanawalt P . DNA sequences that interfere with transcription: implications for genome function and stability. Chem Rev. 2013; 113(11):8620-37. DOI: 10.1021/cr400078y. View

5.
Wang H, Xing J, Grover D, Hedges D, Han K, Walker J . SVA elements: a hominid-specific retroposon family. J Mol Biol. 2005; 354(4):994-1007. DOI: 10.1016/j.jmb.2005.09.085. View